A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot
Clinical trial NCT05536791 · WITHDRAWN
Trial details
- NCT number
- NCT05536791
- Sponsor
- Boehringer Ingelheim
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-24
- Primary completion
- 2024-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.